September 17, 2020

17 Sep 2020 | Lotus Pharma, Chong Kun Dang | Lotus Pharma announces it has signed a commercialisation agreement with Chong Kun Dang for Nesbell® (biosimilar darbepoetin-alpha). Under the agreement, Chong Kun Dang will supply Lotus with Nesbell® for sale in Taiwan, Viet...

August 31, 2020

01 Sep 20 | All | NeuClone Pharma | NeuClone Pharmaceuticals discloses it is working on a biosimilar referencing Keytruda® (pembrolizumab). The product is in the advanced stages of pre-clinical development and is being developed in partnership with the Serum Institute...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags